Navigation Links
AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Date:11/1/2010

ALISO VIEJO, Calif., Nov. 1, 2010 /PRNewswire-FirstCall/ -- AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced a management conference call to discuss the approval of NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) by the U.S. Food and Drug Administration (FDA).  The call is scheduled for today, Monday November 1, 2010 at 5:15 a.m. Pacific time / 8:15 a.m. Eastern time.  

The live call can be accessed by dialing (877) 558-3407 for domestic callers and (706) 679-1941 for international callers.  The conference ID number is 22130601.  A webcast of the live call can be accessed by visiting AVANIR's corporate website at www.avanir.com.  To view the live webcast, please go to AVANIR's website prior to the start of the call to register, download, and install the necessary software.

An archived copy of the webcast will be available on AVANIR's website for 30 days, and a telephone replay will be available through November 6, 2010, by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering the conference ID number 22130601.  

About NUEDEXTA

NUEDEXTA™ is the first and only FDA-approved treatment for pseudobulbar affect (PBA).  NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations.  NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.  

NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA).  PBA occurs secondary to a variety of otherwise unrelated neurologi
'/>"/>

SOURCE AVANIR Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... July 7, 2015 The Global ... million by 2020, growing at an estimated CAGR of 7.6% ... Grand View Research, Inc. Introduction of innovative technologies including hand ... awareness levels pertaining to the advantages of breast milk are ... years. In addition, presence of untapped growth opportunities in emerging ...
(Date:7/7/2015)... , July 7, 2015   InspireMD, Inc. ... a leader in embolic protection systems ("EPS"), today ... Protection System integrated with MicroNet ™ has ... Stent New Product Innovation Award.  Through active market ... analysts and consultants recognize the successful introduction of ...
(Date:7/7/2015)... , July 7, 2015 /PRNewswire/ -- Mindray Medical International ... developer, manufacturer and marketer of medical devices worldwide, ... remaining stake in Wuhan Dragonbio Surgical Implant Co., ... Dragonbio is a domestic medical orthopedic-product provider ... surgical products. Prior to today,s announcement, Mindray already ...
Breaking Medicine Technology:Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4
... , AUSTIN, Texas, Sept. 14 WillWalk, ... forefront of ending Paralysis. WillWalk will raise $3 million to help fund ... Injury (SCI). , , The money raised will fund ... cells being used are a non-controversial adult stem cell from umbilical cord ...
... , SAN DIEGO, Sept. 13 NexBio, Inc. ... against H1N1 influenza and NAI-resistant influenza at the 2009 Interscience ... September 13, 2009, in San Francisco, CA. The work ... Disease Control and Prevention (CDC), University of Hong Kong, and ...
Cached Medicine Technology:Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research 2NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009 2NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009 3
(Date:7/7/2015)... ... 07, 2015 , ... RadSite™, a leading accreditation agency for ... for Medicare and Medicaid Services (CMS), announces that it has updated its website ... The most effective websites are those that provide timely information, frequent updates and ...
(Date:7/7/2015)... ... July 07, 2015 , ... On May 29, 2015, Health Canada announced ... use of gluten-free claims for gluten free oats and foods that contain them as ... Certification Program (GFCP) to include gluten-free oat products in Canada,” says Frank Massong, ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... well-known patient advocate, will be recognized by the White House as a “Champion ... the newly-launched President’s Precision Medicine Initiative, the Champions of Change program recognizes Gleason ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... For over ... medical providers for personal injury victims. Throughout the company’s history the goal has ... the care victims need in their recovery. And while Doctors on Liens has ...
(Date:7/6/2015)... Ca (PRWEB) , ... July 06, 2015 , ... Respected ... awards in 2015, marking him as an attorney who has sharp legal ... received both a Client Distinction Award for 2015 from Martindale-Hubbell and a Top 10 ...
Breaking Medicine News(10 mins):Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3
... level of seriously ill patients. This has paved the way ... ,A study, published in the open access journal BMC ... software that assists in the ,monitoring of glucose levels in ... more efficient than the paper-based method which is currently used ...
... SMS message that has been doing the rounds in Saudi ... which was reportedly smuggled into the kingdom will harm the ... of Health. ,The medicine provides relief from fever ... been aware of this issue for about 23 days. The ...
... oil supplements for health is well known. These contain the ... to be heart-protective. ,It has been found that DHA ... in the foetus therefore pregnant women should consume it. ... is warranted here as well. In this case, the concern ...
... under threat from a drinking problem. This result is based ... Addictions Research of B.C. compared drinking patterns of the province ... the Canadian Addiction Survey done in 2004. ,The findings ... for alcohol consumption and 53 per cent were above less ...
... Institute of Cardiovascular Disease (GICD) have identified a growth factor ... //therapies for cardiovascular diseases. ,the study, published in ... of Sciences, focuses on the role of short RNAs in ... These RNAs also called as miRNAs, could play a key ...
... the University of Chicago have announced findings of archeological evidence ... B.C., leading to the destruction of a city. Clemens Reichel, ... excavation was conducted was a war zone. Artifacts from daily ... Syria at the Iraqi border. ,The findings ...
Cached Medicine News:Health News:Excavations Reveal Clues Of Early Warfare 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: